Modulation of chemokines by poxvirus infections

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 409-412

  Mahalingam, Surendran ^a   Karupiah, Gunasegaran ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Faculty of Medicine   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ANTIVIRAL ACTIVITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; NONHUMAN; POXVIRUS; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0034099723     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00109-6     Document Type: Review

References (36)

1. Mahalingam S., Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol. 77:1999;469-475.
2. Nelson P.J., Krensky A.M. Chemokines, lymphocytes and viruses: what goes around, comes around. Curr Opin Immunol. 10:1998;265-270.
3. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
4. Gale L.M., McColl S.R. Chemokines: extracellular messengers for all occasions? Bioessays. 21:1999;17-28. This paper provides a detailed review of chemokines and chemokine receptors.
5. Ward S.G., Bacon K., Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity. 9:1998;1-11.
6. Lalani A.S., Barrett J.W., McFadden I. Modulating chemokines: more lessons from viruses. Immunol Today. 21:2000;100-106. This paper details the various strategies used by herpesviruses and poxviruses to modulate chemokines.
7. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu Rev Immunol. 18:2000;861-926.
8. Cao J.X., Gershon P.D., Black D.N. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homolog. Virology. 209:1995;207-212.
9. Massung R.F., Jayarama V., Moyer R.W. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homolog. Virology. 197:1993;511-528.
10. Senkevich T.G., Bugert J.J., Sisler J.R., Koonin E.V., Darai G., Moss B. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science. 273:1996;813-816.
11. Bugert J.J., Lohmuller C., Damon I., Moss B., Darai G. Chemokine homolog of molluscum contagiosum virus: sequence conservation and expression. Virology. 242:1998;51-59.
12. Damon I., Murphy P.M., Moss B. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Nat Acad Sci USA. 95:1998;6403-6407.
13. Luttichau B.H., Stine J., Boesen T.P., Johnsen A.H., Chantry D., Gerstoft J., Schwartz T.W. A highly se;ective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med. 191:2000;171-180. This paper describes the finding that human herpesvirus 8 (HHV8) and MCV choose two different ways to interfere with the chemokine system: HHV8 encodes the broad-spectrum chemokine antagonist, vMIP-II, whereas MCV encodes a highly selective CCR8 antagonist, MC148.
14. Ishikawa-Mochizuki I., Kitaura M., Baba M., Nakayama T., Izawa D., Imai T., Yamada H., Hieshima K., Suzuki R., Nomiyama H., Yoshie O. Molecular cloning of a novel CC chemokine, interleukin-11 receptor alpha-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homolog of a CC chemokine encoded by molluscum contagiosum virus. FEBS Lett. 460:1999;544-548. This paper provides the first evidence that MC148R, found in MCV, is likely to have been acquired from the host.
15. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 258:1992;1369-1372.
16. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:1996;17-30.
17. Lalani A.S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol. 71:1997;4356-4363.
18. Lalani A.S., McFadden G. Secreted poxvirus chemokine binding proteins. J Leukoc Biol. 62:1997;570-576.
19. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology. 229:1997;12-24.
20. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., Moyer R.W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 250:1998;173-184.
21. Lalani A.S., Masters J., Graham K., Liu L., Lucas A., McFadden G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M- T1, during myxoma virus pathogenesis. Virology. 256:1999;233-245. The authors show that M-T1 influences the chemotaxis of macrophages into infected tissue sites during the initial phases of virus infection.
22. Alcami A., Symons J.A., Collins P.D., Williams T.J., Smith G.L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol. 160:1998;624-633.
23. Hoffman T.L., Doms R.W. Chemokines and coreceptors in HIV/SIV-host interactions. AIDS. 12:1998;17-26.
24. Emilie D., Galanaud P. Cytokines and chemokines in HIV infection: implications for therapy. Int Rev Immunol. 16:1998;705-726.
25. Chung C.S., Hsiao J.C., Chang Y.S., Chang W. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol. 72:1998;1577-1585.
26. Hsiao J.C., Chung C.S., Chang W. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol. 73:1999;8750-8761.
27. Lalani A.S., Masters J., Zeng W., Barrett J., Pannu R., Everett H., Arendt C.W., McFadden G. Use of chemokine receptors by poxiviruses. Science. 286:1999;1968-1971. The authors demonstrate for the first time that MV uses chemokine receptors to infect cells.
28. Nash P., Barrett J., Cao J., Hota-Mitchell S., Lalani A.S., Everett H., Xu X., Robichaud J., Hnatiuk S., Ainslie C.et al. Immunomodulation by viruses: the myxoma virus story. Ommunol Rev. 168:1999;103-120. This review contains extensive information on the strategies used by MV to subvert the host immune response.
29. Karupiah G., Fredrickson T.N., Holmes K.L., Khairallah L.H., Buller M.L. Importance of interferons in recovery from mousepox. J Virol. 67:1993;4214-4216.
30. Ruby J., Ramshaw I. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10:1991;353-358.
31. Mahalingam S., Karupiah G. Expression of the interferon-inducible chemokines Mig and Crg-2 following vaccinia virus infection in vivo. Immunol Cell Biol. 78:2000;156-160. The authors show, for the first time, the relationship between the IFN-inducible chemokines and IFNs (type I and type II) during a virus infection in vivo.
32. Amichay D., Gazzinelli R.T., Karupiah G., Moench T.R., Sher A., Farber J.M. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol. 157:1996;4511-4520.
33. Ramshaw I.A., Ramsay A.J., Karupiah G., Rolph M.S., Mahalingam S., Ruby J.C. Cytokines and immunity to viral infections. Immunol Rev. 159:1997;119-135.
34. Mahalingam S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J Virol. 73:1999;1479-1491. In this paper, the authors demonstrate for the first time that the chemokines Mig and Crg-2, expressed in vivo at sites of viral replication, can produce an antiviral effect that results in rapid resolution of the rVV infection.
35. Fenner F. Mousepox (infectious ectromelia of mice): a review. J Immunol. 63:1949;341-373.
36. Karupiah G. Type 1 and type 2 cytokines in antiviral defense. Vet Immunol Immunopath. 63:1998;105-109.